Roles of Electrostatics and Conformation in Protein-Crystal Interactions by Azzopardi, Paul V. et al.
Roles of Electrostatics and Conformation in
Protein-Crystal Interactions
Paul V. Azzopardi
1, Jason O’Young
2, Gilles Lajoie
3, Mikko Karttunen
4, Harvey A. Goldberg
1, Graeme K.
Hunter
1*
1School of Dentistry and Department of Biochemistry, University of Western Ontario, London, Ontario, Canada, 2School of Dentistry, University of Western Ontario,
London, Ontario, Canada, 3Department of Biochemistry, University of Western Ontario, London, Ontario, Canada, 4Department of Applied Mathematics, University of
Western Ontario, London, Ontario, Canada
Abstract
In vitro studies have shown that the phosphoprotein osteopontin (OPN) inhibits the nucleation and growth of
hydroxyapatite (HA) and other biominerals. In vivo, OPN is believed to prevent the calcification of soft tissues. However, the
nature of the interaction between OPN and HA is not understood. In the computational part of the present study, we used
molecular dynamics simulations to predict the adsorption of 19 peptides, each 16 amino acids long and collectively
covering the entire sequence of OPN, to the {100} face of HA. This analysis showed that there is an inverse relationship
between predicted strength of adsorption and peptide isoelectric point (P,0.0001). Analysis of the OPN sequence by
PONDR (Predictor of Naturally Disordered Regions) indicated that OPN sequences predicted to adsorb well to HA are highly
disordered. In the experimental part of the study, we synthesized phosphorylated and non-phosphorylated peptides
corresponding to OPN sequences 65–80 (pSHDHMDDDDDDDDDGD) and 220–235 (pSHEpSTEQSDAIDpSAEK). In agreement
with the PONDR analysis, these were shown by circular dichroism spectroscopy to be largely disordered. A constant-
composition/seeded growth assay was used to assess the HA-inhibiting potencies of the synthetic peptides. The
phosphorylated versions of OPN65-80 (IC50=1.93 mg/ml) and OPN220-235 (IC50=1.48 mg/ml) are potent inhibitors of HA
growth, as is the nonphosphorylated version of OPN65-80 (IC50=2.97 mg/ml); the nonphosphorylated version of OPN220-
235 has no measurable inhibitory activity. These findings suggest that the adsorption of acidic proteins to Ca
2+-rich crystal
faces of biominerals is governed by electrostatics and is facilitated by conformational flexibility of the polypeptide chain.
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Introduction
Biomineralization is the controlled deposition of crystals in
tissues such as bones, shells and teeth. The hallmarks of
biomineralization are precise control over crystal type, shape
and orientation, as well as distinct spatial relationships between
mineral and organic matrix [1]. In mammals, the mineral phase is
almost invariably hydroxyapatite (HA; Ca10[PO4]6[OH]2). Ectop-
ic calcification, the formation of crystals in soft tissues such as
cartilage, kidney and blood vessels, is much less organized, often
featuring variable crystal size, random orientation and no
apparent matrix-mineral relationship. Hydroxyapatite (HA) occurs
in calcified blood vessels (atherosclerosis), but many other mineral
phases, including calcium oxalates (kidney stones) and uric acid
(gout) are also found in calcified soft tissues.
Interactions between proteins and crystals are believed to play
important roles in biomineralization [2]. Anionic proteins isolated
from mineralized tissues have been shown to nucleate biomineral
crystals [3,4,5], promote the formation of a particular polymorph
[6,7] or alter crystal growth habit [8,9]. Protein-crystal interactions
are also thought to prevent ectopic calcification [10]. Several
proteins found in soft tissues or tissue fluids inhibit crystal
nucleation and/or growth in vitro [11,12]. Deletion of the genes
encoding such proteins has been shown to result in organ-specific
or systemic calcification [13,14,15,16].
Like many crystal-inhibiting proteins, osteopontin (OPN) is
found both in mineralized and nonmineralized tissues. In vitro,i t
has been shown to inhibit the formation of calcium phosphate,
calcium oxalate and calcium carbonate crystals [17,18,19]. OPN is
a phosphoglycoprotein of approximately 300 amino acids, many of
which are aspartic or glutamic acid [20]. The extent of post-
translational modification of the protein depends both on species
and tissue of origin: cow milk OPN has 28 sites of phosphorylation
[21], with an average phosphate content per molecule of 25 [22];
while rat bone OPN has 29 sites of phosphorylation, with an
average phosphate content of 10 [23].
Phosphate groups present in OPN make a large contribution to
the crystal-inhibiting activity of the protein. Thus, nonpho-
sphorylated forms of OPN or OPN peptides are far less inhibitory
than the corresponding phosphorylated protein/peptide
[9,18,24,25,26]. However, it is not clear whether or not highly
phosphorylated forms of OPN like that from breast milk are
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that from bone [22,27]. Also, it appears that some OPN
phosphopeptides are stronger inhibitors than others of similar
phosphate content [28,29].
The means by which OPN inhibits the formation of biominerals
is also unclear. Studies of calcium oxalate monohydrate (COM)
growth using atomic force microscopy have shown that growth-
hillock structure is disrupted and the rate of step growth decreased
in the presence of OPN [30]. This has been interpreted in terms of
a step-pinning mechanism in which the adsorption of a sufficient
number of OPN molecules to growth steps prevents the steps from
advancing over the crystal face. These studies have also shown that
OPN has a preference for certain types of steps on the COM
crystal [30]. Specificity of interaction is also suggested by our
previous demonstration that a synthetic phosphopeptide corre-
sponding to amino acids 220-235 of rat bone OPN adsorbs
selectively to {100} faces and preferentially inhibits growth in
,100. directions (perpendicular to {100} faces) [9]. The
selectivity of OPN220-235 for the {100} face appears to be due
to the electropositivity of this face compared to the other faces
developed ({010} and {121}) [31].
Far less is known about the interaction between OPN and HA.
Largely this is because most synthetic and biological HA crystals
have dimensions in the order of tens of nanometres – almost three
orders of magnitude smaller than COM crystals.
The lack of experimental approaches to study HA crystal
growth can be to some extent remedied by the use of molecular-
dynamics simulations [32]. In previous studies, we have used
molecular dynamics to study the interaction between the
OPN220-235 peptide and the {100} face of COM. This showed
that the amino acids interacting most closely with the face are
aspartic and glutamic acids, not phosphoserines, and also provided
information about the positions of carboxylate and phosphate
oxygen atoms relative to the Ca
2+ ions of the {100} face [9,33].
For the purposes of the present study, we have now created a
molecular-dynamics simulation of the {100} face of HA. This is
the principal crystal face developed in bioapatites and has been
implicated in the adsorption of other acidic proteins [34,35,36,37].
Using this {100}-face simulation, we have studied the interactions
of a series of virtual peptides covering the entire sequence of rat
bone OPN. To validate the results of the simulations, we
synthesized a peptide predicted to interact strongly with the HA
{100} face and showed, using a constant-composition assay, that
this peptide is a potent inhibitor of the growth of HA crystals. The
results obtained from this study allow us to describe the roles of
charge and conformation in the interaction between OPN and
HA.
Materials and Methods
Molecular-Dynamics Simulations
Atomic-scale molecular-dynamics simulations were performed
using the GROMACS suite [38]. For force field, we used
GROMOS96 version 45A3, which has proven to be a reliable
description for lipids, peptides and other biomolecules [39].
Similar methods and software were used in a previous study of
HA-water interactions [40]. Other studies on HA and related
crystals have used the CHARMM [41,42] or COMPASS [43]
force-fields, as well as a number of individual parameterizations.
The coordinates for the HA {100} face were taken from
previously obtained experimental results [44]. The topologies for
the phosphate and hydroxyl ions was generated using previously
solved atomic charges [45,46] and parameters from the force field
for constraints. Note that our HA simulation does not include the
kinds of imperfections (disclocations, vacancies, step edges, etc.)
that occur in ‘‘real’’ crystals, as these would greatly complicate the
analysis. Simulations by other workers also involve perfect crystal
lattices (for review, see [32,47]).
Extended conformations were used as the initial peptide
structure. For each simulation, peptides were oriented parallel to
the crystal surface where the center-of-mass difference between the
crystal slab and the peptide was approximately 4 nm in the
direction perpendicular to the surface. The crystal slab was placed
at the center of the periodic cell and constructed to be
approximately 1.0 nm thick with the Ca
2+-dense layers of the
{100} face exposed on each side. The simulations were performed
in the NVT ensemble at 300 K and periodic boundary conditions
were applied with the size of the simulation cell being
8.4 nm66.2 nm in the plane of the surface and 10 nm
perpendicular to the surface. The system was solvated with simple
point charge (SPC) water [48] model which is consistent and
proven to work well with the GROMOS96 force field [49]. Cl
-
counter-ions were added to maintain the system charge-neutral.
Prior to the actual simulation runs, energy minimization was
performed without constraints using the steepest descent method.
The bond lengths were constrained using the SHAKE
algorithm [50]. Crystal atoms were constrained to their equilib-
rium positions. 1.0 nm cutoff was used for the Lennard-Jones
interactions as required by the chosen force-field. The weak-
coupling thermostat with a coupling time constant of 0.1 ps was
employed and the particle mesh Ewald method [51,52,53] with
real space cutoff of 1.0 nm, beta-spline interpolation of order 6
and direct sum tolerance of 10
26 was used for electrostatics. Since
the system contains strong charges, it is important to employ
proper treatment of electrostatics (for a comprehensive discussion
see [54]) as cutoffs have been shown to lead to significant artifacts
in biomolecular simulations [52]. The time step was set to 2 fs,
which is the standard when no driving forces, such as shear, are
present. Systems were simulated for 5 ns each. The systems
consisted of total of 49,438–49,485 atoms. The number of water
molecules was about 14,250, varying slightly depending on the
system. All simulations were run in parallel over eight processors
on the SHARCNET grid computing facility (www.sharcnet.ca).
To reduce potential bias due to initial conditions, 6 different initial
conditions were used in all of the cases. In total, 74 simulation runs
were performed.
Distance from the crystal surface for each peptide was
calculated by averaging the center-of-mass position in the vertical
axis of the simulation box over 3 to 5 ns sampled at 20 ps intervals.
The vertical position of the crystal surface atoms was subtracted
from this value to arrive at the final result.
Calculation of Peptide Isoelectric Points
Isoelectric points of OPN virtual peptides were determined
using the calculator developed by Gauci and coworkers. This
instrument calculates the pI of a peptide at a particular pH using
user-specified pK values. The calculation is repeated until the pH
corresponding to a net charge of zero is found [55]. pI values
quoted were calculated using the Scansite and Expasy options.
Synthesis and Characterization of Peptides
OPAR (osteopontin poly-aspartate region: SHDHMDDDDD-
DDDDGD) and pOPAR (pSHDHMDDDDDDDDDGD) pep-
tides were synthesized by a batch method with free amino and
carboxyl termini using Fmoc chemistry and purified by high-
performance liquid chromatography on a C18 column, as
previously described [9,29]. Peptide purity was determined by
electrospray ionization mass spectrometry (OPAR, 1,833.29 Da;
Protein-Crystal Interactions
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Biomolecular Design, University of Alberta, or Advanced Protein
Technology Centre, Hospital for Sick Children, Toronto). The P0
(SHESTEQSDAIDSAEK) and P3 (pSHEpSTEQSDAIDpSAEK)
peptides were those previously described [9].
Circular dichroism studies were performed using a Jasco J-810
spectropolarimeter equipped with a Peltier temperature-control
system. Each peptide was resuspended at a concentration of
0.4 mM in either Ca/PO4 [500 mM Ca(NO3)2, 300 mM
Na2HPO4, 150 mM NaCl, pH 7.4] or HEPES (10 mM HEPES,
100 mM NaCl, 10 mM KCl, pH 7.4) buffer. Scans were recorded
at 37uC from 250 to 190 nm, with a step size of 0.5 nm and a scan
speed of 100 nm/min. A cell with a path length of 0.1 mm was
used. Each peptide solution was scanned 30 times and the resulting
spectra averaged. Blank buffer scans were subtracted from the raw
data, which were then converted to mean residue ellipticity (h)i n
units of degree cm
2 dmol
21 by standard procedures. CDSSTR
and CONTINLL algorithms for the estimation of protein
secondary structure from UV CD spectra were used to analyze
the circular-dichroism spectra generated [56].
Constant-Composition/Seeded-Growth Analyses
HA seed crystals were prepared essentially by the method of
Nancollas and Mohan [57] and characterized by X-ray diffrac-
tometry. Using the Brunauer-Emmett-Teller method, the surface
area of the crystals was shown to be 84.160.094 m
2/g.
A modification of the constant-composition seeded-growth assay
originally developed by Tomson and Nancollas was used [58].
Reaction solutions were prepared by combining 1.25 ml of dH2O
(or protein/peptide dissolved in dH2O), 2 ml of 1.2 mM
Na2HPO4 and 4 ml of 1 mM Ca(NO3)2/300 mM NaCl in a
custom-made double-walled Pyrex vessel with stirring. The
solution was maintained at 3760.1uC using a circulating water
bath connected to the Pyrex vessel. All stock solutions were
previously vacuum-filtered through 0.2 mm-pore-size polyether-
sulfone membranes. A calomel pHC4006 electrode connected to a
TIM900 titration manager (Radiometer) was immersed into the
reaction solution. To exclude atmospheric carbon dioxide, a single
flow tube rotameter was used to bubble 18.3 ml/min of water-
saturated nitrogen through the solution. To provide adequate time
to reach equilibrium, nitrogen flow began one hour prior to the
addition of seed crystals. Prior to the addition of HA seed crystals,
the pH of the metastable solution was adjusted to between 7.40
and 7.41 by the addition of small aliquots of 25 mM NaOH.
Also immersed in the reaction solution were two Teflon titration
probes attached to a Radiometer ABU93 triburet. The triburet
was customized so that two of its 5-ml burets operated in the
‘‘master-slave’’ mode. The ‘‘master’’ buret contained 3.5 mM
Ca(NO3)2/300 mM NaCl and the ‘‘slave’’ buret contained
2.1 mM Na2HPO4/1.6 mM NaOH. Titrant addition was con-
trolled using TimTalk 9 in pH-stat mode with an endpoint pH of
7.40 and proportional band pH of 0.100. The burets were limited
to a minimum speed of 1.0% volume/min and a maximum speed
of 3.0% volume/min.
The reaction was initiated by the addition of 750 ml of a freshly
made HA slurry in dH2O (2.67 mg/ml, unless otherwise stated). The
final reaction solution composition was therefore 0.5 mM Ca(NO3)2,
0.3 mM Na2HPO4, 150 mM NaCl and 0.25 mg/ml HA.
Immediately after the addition of the hydroxyapatite slurry
(time zero) and just prior to the termination of the titration
(240 min), 0.4-ml aliquots were removed from the reaction
solution and filtered through 0.2-mm polyethersulfone membrane
syringe filters. The calcium and phosphate concentrations were
determined spectrophotometrically using the QuantiChrom
TM
Calcium Assay Kit and the Innova Biosciences PiColorLock
TM
Phosphate Assay Kit according to the manufacturers’ instructions.
Results
Molecular-Dynamics Analysis of Peptide-Hydroxyapatite
Interaction
The rat bone OPN sequence was divided into 19 virtual
peptides, each 16 amino acids long. The sequences of these
peptides are shown in Table 1. Note that, because the number of
amino acids in rat OPN (301) is not an exact multiple of 16,
peptides 18 and 19 overlap by three amino acids. Each peptide
was placed in a simulation box containing a section of the {100}
face of HA, Cl
2 counterions and water and subjected to a
molecular-dynamics force-field for 5 ns of simulation time. At the
end of the simulations, the final distance between the peptide
center of mass and the outermost layer of crystal atoms was
calculated (Figure 1A). It can readily be seen that the peptides
forming close contact with the {100} face are those with low
isoelectric points, while the three peptides with near-neutral or
basic isoelectric points are by far the most distant from the face.
No peptide has a center-of-mass distance less than approximately
0.8 nm, which probably represents the closest contact between
peptide and crystal that does not infringe upon the van der Waals’
radii of any atom.
In Figure 2, distance between the peptide center of mass and the
outermost layer of crystal atoms is plotted against isoelectric point.
There is a statistically significant correlation between distance and
pI, such that peptides with lowest pIs approach closest to the
{100} face. This correlation implies that the nature of the amino
acids contributing to the negative charge (aspartic acid, glutamic
Table 1. Amino acid sequence and pI of virtual OPN peptides
used for MD analysis.
Peptide no. Amino acid nos. Sequence
Isoelectric
point
1 1–16 LPVKVAEFGpSpSEEKAH 4.25
2 17–32 YSKHSDAVATWLKPDP 6.75
3 33–48 SQKQNLLAPQNSVpSpSE 3.35
4 49–64 EpTDDFKQETLPpSNpSNE 2.37
5 65–80 pSHDHMDDDDDDDDDGD 3.39
6 81–96 HAEpSEDSVNpSDEpSDES 2.33
7 97–112 HHpSDEpSDESFTASTQA 3.48
8 113–128 DVLTPIAPTVDVPDGR 3.93
9 129–144 GDSLAYGLRSKSRSFP 9.99
10 145–160 VpSDEQYPDApTDEDLTpS 1.79
11 161–176 RMKpSQEpSDEALKVIPV 4.15
12 177–192 AQRLSVPSDQDSNGKT 6
13 193–208 pSHEpSSQLDEPpSVETHS 2.96
14 209–224 LEQSKEYKQRApSHEpST 4.75
15 225–240 EQSDAIDpSAEKPDAID 3.44
16 241-256 pSAERpSDAIDSQASSKA 3.54
17 257–272 pSLEHQpSHEFHpSHEDKL 4.37
18 273–288 VLDPKpSKEDDRYLKFR 5.92
19 286–301 KFRIpSHELEpSpSpSSEVN 3.09
Underlined amino acids in peptides 14 and 15 correspond to the sequence of P3.
doi:10.1371/journal.pone.0009330.t001
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unimportant.
The degree of molecular order of the rat OPN sequence was
analyzed using PONDR (Predictor Of Naturally Disordered
Proteins, www.pondr.com) [59]. As this neural network cannot
account for post-translational modifications, the sequence ana-
lyzed was the primary structure of the protein. A PONDR score of
greater than 0.5 is considered to indicate disorder. The PONDR
analysis of OPN is shown in Figure 1B. Two features are obvious.
First, rat OPN is highly disordered, with the great majority of the
sequence having PONDR scores much greater than 0.5. The only
ordered regions are amino acids 1–31, 131–144 and 265–275.
Second, there is generally an inverse relationship between
PONDR score and peptide distance from the {100} face of HA.
For example, peptides 3–7, which are predicted by molecular
dynamics to interact strongly with the crystal face, are predicted by
PONDR to be highly disordered, while peptide 9 is predicted to
interact poorly and be relatively ordered.
One of the virtual OPN peptides predicted by molecular
dynamics to adsorb most closely with the {100} face of HA is 65–
80, pSHDHMDDDDDDDDDGD, which contains the poly-
aspartic sequence of the protein. A movie of the molecular-
dynamics simulation of the interaction of this peptide with the
{100} face is presented as Movie S1. Distances between the side-
chain centers of mass of OPN65-80 and the outer layer of crystal
atoms were averaged over the period 3–5 ns of simulation time
(Figure 3).Theamino acids furthestfromthe crystal face include the
slightly cationic histidines and the bulky methionine. Those closest
to the face are the single phosphoserine and two aspartic acids.
Generallyspeakingthereisanalternationofcloserandmore-distant
amino acids along the sequence of the peptide. The final (5-nsec)
conformation of OPN65-80 is viewed perpendicular to the {100}
face in Figure 4. The peptide backbone is not straight, and therefore
is not aligned with any row of Ca
2+ ions in the {100} plane.
Virtual peptide VLDPKpSKEDDRYLKFR (peptide 18 in
Table 1) exhibits anomalous predicted adsorption behavior, as its
center-of-mass distance from the {100} face is lower than its
isoelectric point (5.92) would suggest. Interestingly, this peptide has
the highest content of basic amino acids (five). The final (5-nsec)
conformation of VLDPKpSKEDDRYLKFR is shown in Figure 5.
Interaction of the peptide with the {100} face involves the central
acid amino acids (EDD), while the more basic and hydrophobic N-
and C-terminal ends do not form attachments with the crystal.
Secondary Structures of Osteopontin Peptides
Synthetic peptides corresponding to amino acids 65–80 of rat
bone OPN, with or without a phosphate group on the N-terminal
serine, were generated. The non-phosphorylated version is
referred to below as OPAR and the phosphorylated version as
pOPAR. The secondary structures of these synthetic peptides were
analyzed by circular dichroism spectrapolarimetry. Also studied
were the P0 and P3 peptides, corresponding to amino acids 220–
235 of rat bone OPN with or without the three phosphate groups
Figure 2. Relationships between peptide isoelectric point and
predicted adsorption to HA. Peptide-crystal distances and isoelec-
tric points are from Figure 1. Equation of regression line is y=0.323 x–
0.040 (r
2=0.754, P , 0.0001).
doi:10.1371/journal.pone.0009330.g002
Figure 1. Molecular-dynamics analysis of OPN adsorption to
HA and PONDR analysis of OPN structure. A. Distances between
centers of mass of OPN virtual peptides (see Table 1) and outermost
atoms of the {100} face of HA. Error bars represent root mean square
deviations of peptide-crystal distance over 3–5 nsec of simulation.
Numbers above bars are the isoelectric points of the peptides. B.
PONDR analysis of the primary sequence of rat OPN. A score of .0.5 is
indicative of a disordered sequence.
doi:10.1371/journal.pone.0009330.g001
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any one of the virtual peptides analyzed by MD in this study;
rather, it is divided between peptides 14 and 15 (Table 1). Circular
dichroism spectra of these peptides, collected in either HEPES
buffer or calcium phosphate solution, are shown as Figure S1.
Deconvolution of the spectra with the CDSSTR and CONTINLL
algorithms resulted in the secondary-structure contents shown in
Table 2. For both peptides, there is very little difference between
the solutions used. In general, the predicted a-helix content is very
small, there is some b-turn and the highest percentage of ordered
structure is b-strand. For OPAR and pOPAR, approximately 50%
of the peptide is predicted to be unordered; for P0 and P3,
approximately 70% is unordered.
Inhibition of Hydroxyapatite Growth by Osteopontin
Protein and Peptides
The effects of osteopontin peptides on HA formation were
studied using a constant-composition/seeded-growth assay. In this
assay, HA seed crystals are grown in a metastable calcium
phosphate solution and a pH electrode is used to control the
addition of titrant solutions containing the crystal lattice ions (Ca
2+,
PO4
32 and OH
2). If the ratio of ions in the titrants corresponds to
the ratio of ions incorporated into the crystal, the ionic composition
ofthesolutionwillremainconstant.Toensurethatthiswasthecase,
Ca
2+and phosphateconcentrationswere measuredatthebeginning
andend oftheincubation. Ifthedifferencewas greaterthan 5%,the
experiment wasdiscarded. Undertheconditions used,thegrowth of
the crystals is hyperbolic for approximately 60 min and linear
thereafter (Figure 6A). The slope of the linear part of the growth
curve is proportional to seed-crystalweight over the range 0.5–4 mg
witha slopeofunity;that is,doubling ofthe amount ofcrystalresults
in doubling the rate of titrant addition (Figure 6B).
Addition of OPAR or pOPAR causes a dose-dependent
decrease in crystal growth rate (Figure 7A, B). Plots of growth
rate against peptide concentration fit well to exponential-decay
curves, with complete inhibition of growth occurring at the higher
concentrations of peptide used (Figure 7C, D). From these curves,
the following IC50 values were calculated: OPAR, 2.97 mg/ml and
pOPAR, 1.93 mg/ml. Inhibition of HA growth by P0 and P3 was
also studied (Figure 8). P0 was a very poor inhibitor, resulting in a
less-than-10% decrease in titrant addition at a peptide concentra-
Figure 3. Molecular-dynamics analysis of pOPAR adsorption to
HA. Distances between pOPAR side-chain centres of mass and
outermost atoms of the {100} face of HA. Distances were averaged
over 3–5 nsec of simulation time.
doi:10.1371/journal.pone.0009330.g003
Figure 4. Orientation of pOPAR on the {100} face of HA. Peptide is viewed at the end of the 5-ns simulation. Crystal: Ca – green, O – red, P –
orange. Peptide: C – grey, H – white, O – pink, N – purple, P – orange, S – yellow.
doi:10.1371/journal.pone.0009330.g004
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be determined. P3 caused a dose-dependent decrease in crystal
growth rate, corresponding to an IC50 of 1.48 mg/ml (Figure 8B).
Unlike OPAR and pOPAR, however, the P3 inhibition curve did
not decrease to zero, instead reaching a plateau value of
approximately 20% of the control rate.
IC50 data are compared with pI values in Table 3.
Discussion
Because of the lack of physical methods capable of providing
suitable resolution, simulation techniques are increasingly being
used to study adsorption of biomolecules to crystals. In the case of
HA, density-function methods have been used to study the
adsorption of amino acids [60], energy minimization to study the
adsorption of citrate [61] and molecular dynamics to study the
ordering of water molecules [40]. A few studies have modelled the
interactions of proteins or peptides with HA. Using energy
minimization, it was shown the salivary protein statherin adsorbs
equally well to {001}, {010} and {100} faces of HA. This
interaction involved acidic and basic amino acids near the N-
terminus of the protein [62]. Energy minimization has also been
used to model the adsorption to HA of phosphopeptides typical of
mineralized-tissue proteins. Oligomers containing phosphoserine-
aspartic acid dipeptides were reported to interact favourably with
{001} faces of HA [63]. However, a pentapeptide of phosphoser-
ine and glutamic acid was found to adsorb to {010} and {100}
faces in preference to {001} faces [36]. Pan and co-workers used a
combination of molecular dynamics and steered molecular
dynamics to study the adsorption of fibronectin and bone
morphogenetic protein 2. In both cases, carboxylate, amino and
hydroxyl groups were involved in the interaction of the protein
with {001} faces of HA [64,65].
As MD is computationally very intensive, analysis of interac-
tions involving intact proteins at atomic scale is usually not
practical. For a protein like OPN that has substantial sequence
redundancy and lack of secondary/tertiary structure, one solution
is to divide the protein into virtual peptides, many of which have
similar motifs, and analyze the interaction with a crystal face of
each peptide separately. This is the approach that we have
developed to study the interaction between rat bone OPN and the
{100} face of HA. To avoid bias, the peptides were created simply
by dividing the 301-amino-acid sequence into 16-amino-acid
segments starting at the N-terminus (except for a 3-amino-acid
Figure 5. Molecular-dynamics analysis of peptide VLDPKpSKEDDRYLKFR adsorption to HA. Peptide is viewed at the end of the 5-ns
simulation. Ca – green, O – red, P – orange, C – grey, H – white, N – blue.
doi:10.1371/journal.pone.0009330.g005
Table 2. Secondary Structure Compositions of Synthetic OPN
Peptides.
Peptide Buffer
a-helix
(%)
b-strand
(%)
b-turn
(%)
unordered
(%)
OPAR HEPES 3.5 23.1 13.1 59.7
CaPO4 4.1 27.6 14.6 53.0
pOPAR HEPES 2.4 30.4 17.1 49.2
CaPO4 3.7 28.9 18.0 48.6
P0 HEPES 3.1 17.3 9.6 69.8
CaPO4 3.6 12.2 7.4 76.1
P3 HEPES 2.3 15.9 9.2 72.1
CaPO4 3.6 15.2 9.2 71.5
The percent compositions are derived from the circular dichroism spectra
shown in Figure S1 using the CDSSTR and CONTINLL algorithms.
doi:10.1371/journal.pone.0009330.t002
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correspond to known degradation products of rat bone OPN or to
predicted proteolytic cleavage sites.
Because of the large number of peptides to be analyzed, the
simulations here are relatively short in duration (5 ns). This
simulation time is, however, comparable to or longer than those
used recently in similar studies that produced robust results and
reliable comparisons with experimental findings. This is particu-
larly the case for the quantities studied here, as formation of
contacts between the protein and the surface occurs in short time-
scales (,1 ns). In view of the rapid adsorption and multiple bonds
formed, it is unlikely that desorption or conformational change will
Figure 6. Constant-composition/seeded growth assay of HA formation. A. Typical titration curve obtained in the absence of effector. B.
Relationship between rate of titrant addition and amount of seed crystal added. Equation of regression line is y=0.147 x + 0.012 (r
2=0.988,
P , 0.001).
doi:10.1371/journal.pone.0009330.g006
Figure 7. Effects of OPAR and pOPAR on seeded growth of HA. A. Titration curves obtained in the presence of OPAR. Nonlinear parts of the
curves (0–60 min) have been omitted. Labels represent concentration in mg/ml. B. Plot of HA growth rate (see panel A) against OPAR concentration.
The half-life of the one-phase exponential-decay curve (IC50) is 2.97. C. Titration curves obtained in the presence of pOPAR. Nonlinear parts of the
curves (0–60 min) have been omitted. Labels represent concentration inmg/ml. B. Plot of HA growth rate (see panel C) against pOPAR concentration.
The half-life of the one-phase exponential-decay curve (IC50) is 1.93.
doi:10.1371/journal.pone.0009330.g007
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initial peptide orientation on adsorbed conformation will be
studied in detail in a separate publication. This will involve also an
analysis of commensurability effects and free energy.
The 19 virtual peptides of OPN exhibit large differences in
predicted HA-binding behavior, their center-of-mass distances
from the {100} face at the end of the simulation ranging from
about 0.8 nm to just over 4 nm. Those adsorbing most closely to
the crystal have the lowest isoelectric points; those adsorbing least
well have the highest isoelectric points. The correlation between
OPN-peptide net charge and predicted strength of interaction with
the crystal surface suggests that the adsorption of OPN peptides,
almost all of which are acidic, to the basic {100} face of HA is
governed by electrostatics. Based on their studies on the
interaction between a phosphopeptide corresponding to amino
acids 93–106 of human OPN and the {100} face of COM, a
similar conclusion was reached by Wang et al [26]. Electrostatics
has been reported to dominate in the adsorption to HA of peptides
of b-casein [36], fibronectin [65] and statherin [66]. Our recent
analysis of the effects of urinary proteins and model compounds on
calcium oxalate crystal formation also shows that the most potent
inhibitors have high negative charge density and high hydrophi-
licity [67]. These factors have also been implicated in the
enhancement of calcite growth by acidic peptides [68].
The PONDR analysis reported here shows that OPN is
unordered over more than 80% of its sequence. In fact this is
probably an underestimate, as the analysis was performed on the
primary sequence of rat OPN, and post-translational modification
will likely decrease the order further. The high PONDR scores
associated with most of the OPN sequence should come as no
surprise, since it has all the hallmarks of an intrinsically unordered
protein: a high content of charged amino acids, a low content of
hydrophobic amino acids and a high degree of sequence
redundancy [69]. In addition, OPN has been shown to lack
folded structure by NMR spectroscopy and infrared spectroscopy
[27,70]. As shown here and previously by others [26,28], synthetic
peptides corresponding to sequences of OPN are largely
unordered. These findings support suggestions by others that the
flexible conformations of crystal-modulating phosphoproteins
facilitate their interactions with biominerals [70,71].
Comparison of the PONDR analysis of OPN and the
molecular-dynamics analysis of adsorption to the {100} face of
HA shows that strongly interacting regions of the protein tend to
be highly disordered, whereas poorly interacting regions tend to be
relatively ordered. This appears to imply a causal relationship
between molecular disorder and ability to inhibit crystal growth.
However, the inverse relationship between PONDR score and
peptide-crystal distance may simply reflect the fact that high
negative charge density contributes to molecular disorder by
intramolecular electrostatic repulsion. Thus, it may be the charge
density, not the consequent disorder, that determines adsorption
strength and inhibition potency.
One of the virtual peptides predicted to adsorb best to the {100}
face of HA is pSHDHMDDDDDDDDDGD (pOPAR), which is
highly electronegative due to the fact that it contains the so-called
‘‘poly-aspartic acid’’ region of OPN. When the sequence of OPN
was first determined, this region was immediately proposed to be
the HA-binding site [20], although it was many years before any
evidence in support of this proposal was obtained [72]. The
predicted conformation of pOPAR at the end of the MD
simulations described above shows that the peptide is not aligned
with the principal rows of Ca
2+ in the {100} plane, which run
parallel to the crystallographic c axis. Indeed, the peptide
backbone exhibits several bends, resulting in the N-terminal and
C-terminal portions being approximately antiparallel. Non-linear
conformations of crystal-bound peptides have also been predicted
for a lithostatine undecapeptide adsorbed to calcite [73] and a
dentin matrix protein-1 peptide adsorbed to HA [36]. Such
conformations argue strongly against there being any stereochem-
ical relationship between a folded structure of the peptide and an
array of Ca
2+ ions in the crystal lattice.
A synthetic peptide corresponding to the pOPAR sequence was
generated, as was a nonphosphorylated version of the same
sequence (OPAR). In our previous studies on the OPN-COM
interaction, we validated our molecular-dynamics analysis by
Figure 8. Effects of P0 and P3 on seeded growth of HA. A. Plot of HA growth rate against P0 concentration. B. Plot of HA growth rate against
P3 concentration. The half-life of the one-phase exponential-decay curve (IC50) is 1.48.
doi:10.1371/journal.pone.0009330.g008
Table 3. Inhibitory potencies of osteopontin peptides.
Peptide pI IC50 (mg/ml) IC50 (mM)
OPAR 3.60 2.97 1.62
pOPAR 3.39 1.93 0.867
P0 4.17 .75 .42.6
P3 2.92 1.48 0.750
Isoelectric point of pOPAR is from Table 1. Isoelectric points of OPAR, P0 and P3
were derived as described in Experimental Procedures. IC50 values were derived
from the data shown in Figures 7 and 8.
doi:10.1371/journal.pone.0009330.t003
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235 (P3) to adsorb to COM crystals by confocal microscopy, and
its effect on crystal growth habit by growing COM in the presence
of peptide and determining crystal size by scanning electron
microscopy [9]. Neither technique is feasible for HA, which
typically forms much smaller crystals. Therefore, we studied the
effects of OPAR and pOPAR on HA formation using a constant-
composition/seeded-growth method.
Constant-composition growth of HA seed crystals, originally
developed by Tomson and Nancollas [58], is the most rigorous
quantitative method for studying HA formation. Because it
involves growth of seed crystals, a much lower supersaturation
can be used than is required for spontaneous nucleation of HA.
Because a constant supersaturation is maintained by addition of
Ca
2+,P O 4
3- and OH
- to replace those incorporated into the seed
crystals, linear growth occurs. The constant-composition/seeded
growth method has been widely used to study inhibitors of HA and
other crystal phases [26,74,75,76].
As previously noted by others, linear growth of HA seed crystals
under constant-composition conditions only occurs after an initial
period of non-linear growth [77,78]. During the non-linear growth
period, the seed crystals are growing at edges, kinks and screw
dislocations. Once the edges and kinks are filled in, growth occurs
only at screw dislocations [79].
In plots of linear growth rate against peptide concentration, the
data fall on simple exponential decay curves, allowing us to
calculate IC50 values for OPAR and pOPAR of 2.97 and 1.93 mg/
ml, respectively. The small magnitude of this difference may seem
surprising, in view of the abundant literature showing that
phosphorylation of OPN is critical for its crystal-inhibiting
activities (see Introduction). Even without a phosphate group,
however, OPAR has a pI of 3.60, which our molecular-dynamics
analysis predicts will result in strong interaction with the {100}
face of HA (see Figure 2).
For purposes of comparison, we also performed constant-
composition/seeded-growth analysis on peptides P3 and P0. The
IC50 for P3, 1.48 mg/ml, is lower than those of OPAR and
pOPAR, whereas the weak inhibitory activity of P0 meant that no
IC50 value could be determined. The isoelectric point of P3 is 2.92.
According to the relationship we have derived between pI and
predicted {100}-face binding, P3 would be expected to be a strong
inhibitor of HA growth. The isoelectric point of P0, 4.17,
corresponds to a predicted peptide-crystal distance of approxi-
mately 1.4 nm, intermediate between the strongest (,0.8 nm) and
weakest (,3 nm) OPN peptides (Figure 2). One might therefore
expect that P0 would have stronger inhibitory activity than that
measured by our constant-composition analysis. However, we
have previously shown that differently phosphorylated proteins
and peptides can adsorb equally well to COM crystals but vary
widely in inhibitory activity [9,22]. It may well be that fairly small
differences in occupancy time on the crystal surface are crucial in
determining whether or not step-pinning occurs. Also, the uptake
of lattice ions measured in our constant-composition assay
represents the growth of all faces present. A peptide of
intermediate pI such as P0 may adsorb poorly to faces less basic
than {100}.
We previously used a constant-composition method to study the
inhibition of spontaneous (non-seeded) formation of HA by OPN
phosphopeptides. This showed that peptides corresponding to
sequences 41–52 (PQNSVpSpSEETDD) and 290–301 (SHE-
LEpSpSpSSEVN) of rat bone OPN are more potent inhibitors of
HA nucleation than peptide 7–17 (EFGpSpSEEKAHY) or 248–
264 (IDpSQASSKApSLEHQpSHE) [29]. These peptides have
isoelectric points of 2.09, 2.36, 3.70 and 3.93, respectively
(calculated as described in Experimental Procedures). In agreement
withthe findings of the present study, therefore, the more-inhibitory
peptides have lower isoelectric points than the less-inhibitory ones.
It is important to bear in mind that the IC50 values reported
here reflect only one aspect of a peptide’s HA-inhibiting activity.
For OPAR and pOPAR, the inhibition curves reach an asymptote
at a growth rate of zero. For P3, the asymptote is reached at
approximately 20% of the control rate. Therefore, based on IC50
values, P3 is a stronger inhibitor than OPAR; based on maximal
inhibitory effect, OPAR is the stronger inhibitor. It is not clear
why some peptides can completely inhibit HA growth while others
apparently cannot.
In conclusion, we have demonstrated the feasibility of using
molecular dynamics as a screening technique to identify crystal-
binding sequences in proteins. The sequences in rat bone OPN
predicted to interact most strongly with the basic {100} face of HA
have low isoelectric points due to the presence of aspartic acid,
glutamic acid, phosphoserine and/or phosphothreonine residues.
These sequences are also highly unordered, which may facilitate
their interactions with Ca
2+ ions of the crystal surface. In agreement
with this model of protein-crystal interactions, we have synthesized
highly anionic peptides based on sequences in OPN and shown that
these are both unordered and potent inhibitors of HA growth.
Supporting Information
Figure S1 Cicular dichroism spectropolarimetry of synthetic
osteopontin peptides. Panels A and C: samples dissolved at 0.4 mM
100 mM NaCl, 10 mM KCl, 10 mM HEPES, pH 7.4. Panels B
and D: samples dissolved at 0.4 mM in 150 mM NaCl, 500 mM
Ca(NO3)2,3 0 0mMN a 2HPO4, pH 7.4. Spectra were collected on a
Jasco J-810 spectropolarimeter at 37uC with a step size of 0.5 nm
and a scan speed of 100 nm/min, using a 0.1-mm path-length cell.
Found at: doi:10.1371/journal.pone.0009330.s001 (14.63 MB
TIF)
Movie S1 Video of pOPAR peptide adsorption to the {100}
face of hydroxyapatite. Colour scheme as described in Figure 5.
Found at: doi:10.1371/journal.pone.0009330.s002 (1.62 MB
MPG)
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